E de Clercq - JoVE Visualize

Showing results (301-310 of 1,143) with videos related to

Pageof 115

Sort By:

FEBS Letters|June 3, 1985

Murine mammary FM3A carcinoma cells transformed with the herpes simplex virus type 1 thymidine kinase gene are highly sensitive to the growth-inhibitory properties of (E)-5-(2-bromovinyl)-2'-deoxyuridine and related compoundsJ Balzarini, E de Clercq, D Ayusawa, et al.

Nucleic Acids Symposium Series|January 1, 1986

Differential inhibitory effects of Evans blue on various DNA polymerasesH Nakane, J Balzarini, E De Clercq, et al.

Journal of Medicinal Chemistry|May 1, 1985

Synthesis and antiviral activity of the carbocyclic analogues of (E)-5-(2-halovinyl)-2'-deoxyuridines and (E)-5-(2-halovinyl)-2'-deoxycytidinesP Herdewijn, E De Clercq, J Balzarini, et al.

Biochimica Et Biophysica Acta|April 29, 1998

Selection and characterisation of murine leukaemia L1210 cells with high-level resistance to the cytostatic activity of the acyclic nucleoside phosphonate 9-(2-phosphonylmethoxyethyl) adenine (PMEA)J Balzarini, S Hatse, L Naesens, et al.

AIDS Research and Human Retroviruses|March 10, 1998

Lamivudine resistance of HIV type 1 does not delay development of resistance to nonnucleoside HIV type 1-specific reverse transcriptase inhibitors as compared with wild-type HIV type 1H Jonckheere, M Witvrouw, E De Clercq, et al.

Journal of Medicinal Chemistry|May 23, 1998

cycloSal-2',3'-dideoxy-2',3'-didehydrothymidine monophosphate (cycloSal-d4TMP): synthesis and antiviral evaluation of a new d4TMP delivery systemC Meier, M Lorey, E De Clercq, et al.

Journal of Acquired Immune Deficiency Syndromes|January 1, 1990

Potentiating effect of ribavirin on the in vitro and in vivo antiretrovirus activities of 2',3'-dideoxyinosine and 2',3'-dideoxy-2,6-diaminopurine ribosideJ Balzarini, L Naesens, M J Robins, et al.

Antiviral Research|August 1, 1997

Bicyclams, a class of potent anti-HIV agents, are targeted at the HIV coreceptor fusin/CXCR-4D Schols, J A Esté, G Henson, et al.

Antiviral Research|November 1, 1996

Novel L-lyxo and 5'-deoxy-5'-modified TSAO-T analogs: synthesis and anti-HIV-1 activityS Ingate, E De Clercq, J Balzarini, et al.

Antiviral Research|April 25, 2000

Inhibitory effects of EICAR on infectious pancreatic necrosis virus replicationM Jashés, G Mlynarz, E De Clercq, et al.

Pageof 115

Showing results (301-310 of 1,143) with videos related to

Sort By:

Pageof 115

FEBS Letters|June 3, 1985

Murine mammary FM3A carcinoma cells transformed with the herpes simplex virus type 1 thymidine kinase gene are highly sensitive to the growth-inhibitory properties of (E)-5-(2-bromovinyl)-2'-deoxyuridine and related compoundsJ Balzarini, E de Clercq, D Ayusawa, et al.

Nucleic Acids Symposium Series|January 1, 1986

Differential inhibitory effects of Evans blue on various DNA polymerasesH Nakane, J Balzarini, E De Clercq, et al.

Journal of Medicinal Chemistry|May 1, 1985

Synthesis and antiviral activity of the carbocyclic analogues of (E)-5-(2-halovinyl)-2'-deoxyuridines and (E)-5-(2-halovinyl)-2'-deoxycytidinesP Herdewijn, E De Clercq, J Balzarini, et al.

Biochimica Et Biophysica Acta|April 29, 1998

Selection and characterisation of murine leukaemia L1210 cells with high-level resistance to the cytostatic activity of the acyclic nucleoside phosphonate 9-(2-phosphonylmethoxyethyl) adenine (PMEA)J Balzarini, S Hatse, L Naesens, et al.

AIDS Research and Human Retroviruses|March 10, 1998

Lamivudine resistance of HIV type 1 does not delay development of resistance to nonnucleoside HIV type 1-specific reverse transcriptase inhibitors as compared with wild-type HIV type 1H Jonckheere, M Witvrouw, E De Clercq, et al.

Journal of Medicinal Chemistry|May 23, 1998

cycloSal-2',3'-dideoxy-2',3'-didehydrothymidine monophosphate (cycloSal-d4TMP): synthesis and antiviral evaluation of a new d4TMP delivery systemC Meier, M Lorey, E De Clercq, et al.

Journal of Acquired Immune Deficiency Syndromes|January 1, 1990

Potentiating effect of ribavirin on the in vitro and in vivo antiretrovirus activities of 2',3'-dideoxyinosine and 2',3'-dideoxy-2,6-diaminopurine ribosideJ Balzarini, L Naesens, M J Robins, et al.

Antiviral Research|August 1, 1997

Bicyclams, a class of potent anti-HIV agents, are targeted at the HIV coreceptor fusin/CXCR-4D Schols, J A Esté, G Henson, et al.

Antiviral Research|November 1, 1996

Novel L-lyxo and 5'-deoxy-5'-modified TSAO-T analogs: synthesis and anti-HIV-1 activityS Ingate, E De Clercq, J Balzarini, et al.

Antiviral Research|April 25, 2000

Inhibitory effects of EICAR on infectious pancreatic necrosis virus replicationM Jashés, G Mlynarz, E De Clercq, et al.

Pageof 115